BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6330700)

  • 1. [Immunologic response and prognosis in patients with breast cancer. II. Prognostic value of morphological and functional indicators of cellular response].
    Smolak K
    Nowotwory; 1984; 34(1):21-30. PubMed ID: 6330700
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the tumor cell-lymphocyte interaction in patients with breast cancer.
    Deodhar SD; Crile G; Esselstyn CB
    Cancer; 1972 May; 29(5):1321-5. PubMed ID: 4336633
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinoma.
    Tanaka H; Shimoda T; Uchida K; Suzuki T; Ishikawa E
    Acta Pathol Jpn; 1986 Oct; 36(10):1455-68. PubMed ID: 3026138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased T-lymphocytes in patients with mammary cancer.
    Keller SE; Ioachim HL; Pearse T; Siletti DM
    Am J Clin Pathol; 1976 Apr; 65(4):445-9. PubMed ID: 178170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoid cells in the venous blood of 100 female patients with breast carcinoma. Follow-up studies].
    Lellé RJ; Heidenreich W; Peter HH
    Onkologie; 1985 Aug; 8(4):241-5. PubMed ID: 3005936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of tumor extracts on lymphocyte transformation in peripheral blood cultures of healthy persons and patients with breast cancer.
    Golob E; Fischer P; Holzner H; Kunze-Mühl E
    Z Krebsforsch; 1969; 72(2):155-61. PubMed ID: 4306552
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity.
    Amaral L; Werthamer S
    Nature; 1976 Aug; 262(5569):589-90. PubMed ID: 8726
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
    Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA
    Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral mammary carcinoma; immunologic implications.
    Bloom ND; Daluvoy RV; Ceccarelli F; Degenshein GA
    N Y State J Med; 1980 May; 80(6):908-10. PubMed ID: 6250105
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophages in human breast disease: a quantitative immunohistochemical study.
    Kelly PM; Davison RS; Bliss E; McGee JO
    Br J Cancer; 1988 Feb; 57(2):174-7. PubMed ID: 2833921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-biopsy breast carcinoma: a natural experiment in cancer immunology.
    Black MM; Cutler SJ; Barclay TH
    Cancer; 1972 Jan; 29(1):61-5. PubMed ID: 4332318
    [No Abstract]   [Full Text] [Related]  

  • 13. The lymphocyte locomotion assay in colon and breast cancer long survivors.
    Fazio M; Calabrese F; Giacomasso S; Negri L; Mastromatteo V
    Panminerva Med; 1993 Mar; 35(1):16-21. PubMed ID: 8391132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
    Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
    Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local cellular and tributary lymphocyte immunity in cancer of the breast. Diagnostic and prognostic evaluations].
    Boscaino N; De Falco A
    Arch Sci Med (Torino); 1978; 135(2):209-18. PubMed ID: 210742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic sampling analysis of the immune status of breast cancer patients].
    Eremina OF; Kunitsyna TA; Sharonina AI
    Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell mediated immune status in carcinoma breast.
    Mohanty I; Nayak M; Nanda BK
    Indian J Pathol Microbiol; 1991 Jan; 34(1):1-6. PubMed ID: 1665479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
    Sironi M; Cantaboni A
    Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.
    Schoorl R; Riviere AB; Borne AE; Feltkamp-Vroom TM
    Am J Pathol; 1976 Sep; 84(3):529-44. PubMed ID: 183507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.